The Oncology Institute, Inc.TOINASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank57
3Y CAGR-7.7%
5Y CAGR+18.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-7.7%/yr
vs +58.0%/yr prior
5Y CAGR
+18.6%/yr
Recent deceleration
Acceleration
-65.7pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $105.57M | -7.5% |
| 2024 | $114.11M | -16.5% |
| 2023 | $136.59M | +1.9% |
| 2022 | $134.04M | +54.6% |
| 2021 | $86.71M | +92.4% |
| 2020 | $45.07M | +38.3% |
| 2019 | $32.59M | +51.6% |
| 2018 | $21.49M | - |